The novel class of GLP-1 agonist medication and GIP dual medications, including tirzepatide, semaglutide, and the relatively introduced retatrutide, provide promising improvements in metabolic management . https://cjc-1295688742.imblogs.net/93623876/semaglutide-a-comparative-look